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Cell Biology
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mammary gland by introduction of simian virus 40 large tumor
antigen with a recombinant retrovirus
(milk epithelial cells/ras gene)
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ABSTRACT When defined in terms of markers for normal
cell lineages, most invasive breast cancer cells correspond to the
phenotype of the common luminal epithelial cell found in the
terminal ductal lobular units. Luminal epithelial cells cultured
from milk, which have limited proliferative potential, have now
been immortalized by introducing the gene encoding simian
virus 40 large tumor (T) antigen. Infection with a recombinant
retrovirus proved to be 50-100 times more efficient than
calcium phosphate transfection, and ofthe 17 cell lines isolated,
only 5 passed through a crisis period as characterized by
cessation of growth. When characterized by immunohis-
tochemical staining with monoclonal antibodies, 14 lines
showed features of luminal epithelial cells and of these, 7
resembled the common luminal epithelial cell type in the profile
of keratins expressed. These cells express keratins 7, 8, 18, and
19 homogeneously and do not express keratin 14 or vimentin;
a polymorphic epithelial mucin produced in vivo by luminal
cells is expressed heterogeneously and the pattern offibronectin
staining is punctate. Although the cell lines have a reduced
requirement for added growth factors, they do not grow in agar
or produce tumors in the nude mouse. When the v-Ha-ras
oncogene was introduced into two of the cell lines by using a
recombinant retrovirus, most of the selected clones senesced,
but one entered crisis and emerged after 3 months as a
tumorigenic cell line.
In the development of cancer, the changes which occur and
eventually induce malignancy are expressed on the back-
ground of an individual cell phenotype, and specific features
of this phenotype may play a role in the progression to
invasive cancer. In attempting to study carcinogenesis in
vitro it is therefore important to work with the appropriate
cells from the tissue in which a cancer develops in vivo.
Breast carcinomas develop from epithelial cells in the mam-
mary gland. When the phenotype of the invasive cell is
defined in terms of markers relating to the normal cell
lineages, it is most frequently found to correspond to that of
the luminal epithelial cell found in the terminal ductal lobular
unit (TDLU) (1, 2). For in vitro studies on carcinogenesis in
the human mammary gland, it is therefore crucial to be able
to culture these luminal cells.
Human milk represents a unique source of differentiated
luminal epithelial cells uncontaminated by fibroblasts, and
relatively homogeneous cultures of the epithelial cells can be
obtained from this source (3-5). The cells, however, have a
short life-span in vitro, limiting their use. On the other hand,
the long-term cultures and immortal lines developed from
reduction mammoplasty tissue do not exhibit the phenotype
of the luminal cell (6, 7). In an attempt to extend the
proliferative potential of the cells cultured from milk we have
introduced oncogenes that have been reported to immortalize
other cell types. Here we report the development of nontu-
morigenic immortal cell lines from cells in the luminal cell
lineage which correspond in their phenotype to the luminal
cells of the TDLU. These lines represent a unique resource
for studying carcinogenesis in the mammary gland.
MATERIALS AND METHODS
Cell Culture and Introduction of Oncogenes. Media. Pri-
mary cells from samples of human early lactation milk were
grown in medium RPMI 1640 supplemented with 10%o fetal
calfserum (GIBCO), 10% human serum (Flow Laboratories),
bovine insulin (Sigma) at 10 jg/ml, hydrocortisone (Sigma)
at 5 ,ug/ml, cholera toxin (Schwarz/Mann) at 50 ng/ml, and
antibiotics (5). Epithelial cell strains and lines derived from
milk cultures via transfection or retroviral infection were
maintained in Dulbecco's modified Eagle's medium (DMEM)
with 10% fetal calf serum, insulin at 10 pg/ml, and hydro-
cortisone at 5 ,ug/ml (DMEM-SIH). NIH 3T3, /-2 (8), and
PA317 (9) cell lines were cultured in DMEM plus 10o
newborn calf serum (GIBCO).
Calcium phosphate-mediated transfection. Primary hu-
man milk cells from subconfluent cultures (2-3 weeks in
vitro) were trypsinized, washed in serum-containing medium,
and replated at 3-5 x 105 cells in DMEM-SIH. Two to 3 hr
later the cells were transfected with 1 jig of simian virus 40(SV40) DNA (BRL) and 10 pug of calf thymus carrier DNA
coprecipitated with calcium phosphate at pH 7.05 (10), car-
rier DNA alone being used for the control dishes. After 5 hr
at 370C, dishes were rinsed and cells were re-fed with warm
DMEM-SIH. Any cells that had not attached were pelleted
and added back to the original dish. Medium was changed
every 3-4 days, until after 3-6 weeks colonies could be
ring-cloned and expanded.
Retroviral vectors and infection procedure. Recombinant
viruses based on ZipneoSV(X) (11) were developed by in-
serting the SV40 large tumor (T) antigen gene (12), the
adenovirus early region IA protein gene (13), or v-Ha-ras (14)
into the BamHI site. Dok-v-myc (15) was used for introduc-
tion of the myc oncogene. pZiprashygro was derived from
Abbreviations: TDLU, terminal ductal lobular unit; SV40, simian
virus 40; T antigen, large tumor antigen; PEM, polymorphic epithe-
lial mucin.
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pZiprasmyc (16) by exchanging the Bgl II fragment including
the v-myc gene with a Bgl II fragment including the hygro-
mycin-resistance gene hph (15). Ziphygro was derived from
the pZiprashygro virus by deleting a 750-base-pair (bp)
BamHI fragment containing the coding sequences of v-Ha-
ras (E. M. Shaufer and H. Land, personal communication).
Ecotropic recombinant retroviruses produced from /-2 cells
were used to infect PA137 cells to produce amphotropic
virus. Titers (1 x 103 to 2 x 104 colony-forming units/ml)
were one to two orders of magnitude lower than the corre-
sponding ecotropic viral stocks, that of the ZipneoSV virus
carrying the SV40 T antigen gene being the highest.
Subconfluent primary milk cultures were trypsinized and
replated as described above and infected with supernatants
containing amphotropic virus for 4 hr in the presence of
Polybrene (Sigma) at 8 ,ug/ml; 3-5 days later RPMI-SIH
containing G418 (GIBCO) at 800 ,ug/ml or hygromycin at 400
,ug/ml was added. Control dishes were infected with Zip-
neoSV(X) or Ziphygro. Resistant colonies were either fixed
and stained for efficiency estimation or ring-cloned for ex-
pansion and analysis of individual strains. These experiments
have been carried out in accordance with the British Advis-
ory Committee for Genetic Manipulation/Health and Safety
Executive guidelines, note 5.
Immunofluorescence and Antibodies. Methanol/acetone-
fixed cultures were stained by the indirect immunofluores-
cence technique as previously described (1). The antibodies
used were HMFG-1 and HMFG-2 directed to polymorphic
epithelial mucin (PEM) (17), BA16 to keratin 19 (1), C04 to
keratin 18 (18), LL001 to keratin 14 (2), M20 to keratin 8 (19),
RCK105 to keratin 7 (20), DP15 to desmoplakin (21), FN-3 to
fibronectin (22), PAb 419 and PAb 423 to SV40 T antigen (23),
PAb 421 to p53 (23), and V9 to vimentin (Boehringer).
RESULTS
Phenotype of Cells Cultured from Milk. Clumps of epithelial
cells found in early lactation and postweaning samples of milk
can be cultured with the milk macrophages, which act as
feeders (4, 5). The epithelial cells proliferate, displace the
macrophages, and give rise to compact colonies where the
cells may be cuboidal as seen in Fig. la or more elongated.
The cells in these colonies have been shown to have the
phenotype of the luminal epithelial cells; they express kera-
tins 7, 8, and 18 homogeneously and keratin 19 heteroge-
neously. Approximately 30% of the colonies express keratin
14, which appears to be induced by culture in some luminal
cells (2). The cells also express in a heterogeneous fashion a
PEM expressed by the luminal cells in vivo. Fibronectin is
seen as a punctate surface pattern rather than as the extra-
cellular fibrous network typical of mesenchymal cells (24).
In addition to the compact epithelial colonies, an "open"
type of colony is seen in some primary cultures, where
moderately elongated cells grow as a group but unattached to
each other (4). These cells have a less-well-developed keratin
FIG. 1. Morphology of cells in milk cultures (a, b) and in SV40
transformants (c-f). (a) Epithelial colony phenotype seen in primary
milk cultures. (b) Elongated cell type seen when milks are passaged.
(c) Cell line MTSV1-4 passage 4, showing A phenotype. (d) Senes-
cing cell strain MRSV-5.1 passage 5, showing C phenotype. (e) Cell
line MRSV-1.2 showing A/B phenotype at passage 6 stained with
antibody to vimentin to show heterogeneity. (f) Cell line MRSV-3.3
showing B phenotype at passage 30. (x40.) See Table 1 for descrip-
tion of phenotype.
network and a high proliferative potential; there is some
evidence that they are precursors of the colonies of cuboidal
cells mentioned above (25). Finally, if milk cells are pas-
saged, a very elongated cell can emerge (see Fig. lb). These
"late" milk cells express vimentin and an extracellular
fibronectin network, but they can be distinguished from
breast fibroblasts on the basis of their pattern of junctional
communications (26). It is likely that they originate from a
cell type unrelated to the luminal cell (e.g., myoepithelial or
myoblast), which may be found in small numbers in milk.
Isolation of Cell Lines and Strains from Milk Epithelial
Cells. In an attempt to immortalize the milk epithelial cells,
four different oncogenes were tested by calcium phosphate
transfection and/or by retrovirus infection. In several exper-
iments, using early region IA, v-myc, H-ras, and SV40 T
antigen genes, the only oncogene found to induce an ex-
tended life-span was SV40 T antigen. More clones appeared
after retrovirus infection (30-100 clones per dish) than after
transfection (1-2 clones per dish). Accordingly, clones with
an extended life-span were isolated from one transfection
Table 1. Phenotypes of cell strains with extended life-span isolated from milk epithelial cells by introduction of
SV40 T antigen
Expression of protein Pattern of
fibronectin
Phenotype Desmoplakin Vimentin Keratins PEM staining
A + - Basket-like Strongly heterogeneously Punctate
positive
A/B* - + Basket-like and Heterogeneously positive Punctate and short
irregular fibers
C - + Irregular pattern Weak/negative Fibers
Phenotypes A, A/B, and C are shown in Fig. 1 c, e, and d, respectively.
*Mixture of cells showing the A phenotype and cells expressing vimentin, short fibers of fibronectin, little or no
desmoplakin, and an irregular pattern of keratin filaments (B phenotype).
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Table 2. Crisis and emergence of immortal cell lines
No. of No. of Total no.
colonies with strains of immortal
extended showing cell lines
Phenotype life-span crisis* emerging
At 17 8 (4) 13
A/Bt 4 1(0) 4
C 9 9(9) 0
*Number of cell strains that did not survive crisis is given in
parentheses.
tAfter crisis, MRSV4.3 adopted features of cells of the B phenotype
(see Table 3).
tMRSV-1.2 and MRSV-2.1 were later cloned and a cell line with the
A phenotype was selected. With prolonged passage, MRSV-2.3 and
MRSV-3.3 showed the B phenotype homogeneously (see Table 3).
experiment and from five experiments using the recombinant
retrovirus.
The cell strains developed from the selected clones were
examined in early passage for their morphology and expres-
sion of epithelial specific markers (see Table 1). Two main
classes were seen, corresponding in morphology to the
compact epithelial colonies and the highly elongated cells
seen in the late milk cultures (see Fig. 1 c and d, respectively).
Only the epithelial clones went on to become immortalized
lines. All 9 clones selected with the elongated morphology
shown in Fig. ld (phenotype C) entered crisis in early passage
and did not emerge (see Table 2).
When characterized by immunohistochemical staining,
most of the epithelial strains similar to the one shown in Fig.
ic resembled the cells in the compact colonies seen in
primary milk cultures. The cells expressed organized keratin
filaments leading into well-developed desmosomes, high lev-
els of PEM, and the punctate pattern of fibronectin expres-
sion typical of milk epithelial cells; they did not express
vimentin. We refer to this phenotype as the A phenotype. In
four cases, however, a heterogeneity in the antigenic phe-
notype was seen, with some cells in the culture showing the
A phenotype and others characterized by irregular keratin
filaments collapsed around the nucleus and the expression of
vimentin and short fibers of fibronectin (B phenotype; see
Table 1). An example of this mixed A/B phenotype (line
MRSV-1.2) showing heterogeneous staining with vimentin is
shown in Fig. le. Twenty-one clones were selected that
showed the A or A/B phenotype, and 17 went on to become
cell lines, in most cases without passing through a crisis
period (see Tables 2 and 3). Of these, 14 were of the A
phenotype, while 3 showed the B phenotype (see legends to
Tables 2 and 3 and Fig. lf).
Detailed Phenotypes of Immortalized Lines. With the ex-
ception of the cell line MRSV-4.3, which changed from
phenotype A to B after crisis, and the lines that were initially
mixed (see Table 2), the cell lines showed the same pheno-
type immunohistochemically at early and late passage. The
phenotypes in Table 3 were determined after the cells had
been in culture for 11-13 months, and they may be considered
stable features of the lines. According to their reaction with
the antibodies, the cell lines can be considered to fall into four
groups. Groups 1-3 all show the A phenotype, and differ only
in the profile of keratins they express, while group 4 includes
the three cell lines that show features ofthe B phenotype. Fig.
2 illustrates some ofthe staining patterns seen in the cell lines,
and it also shows the pattern of expression of fibronectin by
one of the senescing cell strains of the C phenotype.
Icharacterization of cell lines with
monoclonal antibodies
Tumor growth Staining with
Pheno- in nude antibody to keratint
type Cell line* mouse Crisis 7, 8, 18 19 14
A Group 1t
MTSV-1.4 NT None + +
MTSV-1.7 - None + +
MRSV-1.2 - None + +
MRSV-2.1 - p. 6 + + -
MRSV-2.2 NT p. 12 + + -
MRSV-2.4 NT None + +
Group 2
MRSV-3.1 - None + + +
MRSV-4.1 NT None + +
MRSV-4.5 NT p. 10 + + +
MRSV-5.4 - None + + +
Group 3
MTSV-1.5 NT p. 5 + - +
MRSV-4.2 NT None + - +
MRSV-4.4 - None + - +
MRSV-4.6 NT None + -
B Group 4
MRSV-2.3 NT None + +
MRSV-3.3 NT None +
MRSV-4.3 NT p. 18 + - -
NT, not tested; p., passage.
*MTSV lines were derived by transfection. MRSV lines were
developed by retrovirus infection.
tFor antibodies used see Materials and Methods. +, Homogene-
ously positive staining; ±, heterogeneously positive; -, negative.
*Same phenotype as most luminal cells in TDLU and most breast
cancers.
FIG. 2. Indirect immunofluorescent staining of immortal cell
lines. (a-e) A phenotype. (g and h) B phenotype. (f) Senescing cell
strain (MRSV-5.1) with C phenotype. Cells were fixed and stained
with antibodies to the following proteins: a, keratin 19 (MRSV-1.2);
b, desmoplakin (MTSV-1.7); c, PEM (MRSV-3.1); d, fibronectin
(MTSV-1.4); e, keratin 14 (MRSV-3.1); f, fibronectin (MRSV-5.1
senescing cell strain); g, vimentin (MRSV-3.3); and h, fibronectin
(MRSV-3.3). (a-f x160, g and h x40.)
Table 3. immunonistocnemicai
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The 7 lines in group 1 that show homogeneous expression
of keratins 7, 8, 18, and 19, do not express keratin 14 or
vimentin, have well-developed desmosomes, and express
PEM resemble the dominant luminal epithelial cell found in
the TDLU in vivo. Clearly the cells that were immortalized
to give these lines do not respond to culture conditions by
expressing keratin 14. This is an extremely important phe-
notype, since it corresponds to that of the majority of
invasive breast cancer cells which also express keratin 19,
and do not, even after years in culture, express keratin 14 (4).
Growth Properties of the Cell Lines. After transfection or
retroviral infection the surviving cells were cultured in
DMEM-SIH, which does not support the growth of normal
milk cells. At later passages, all the lines were able to grow
in the absence of hydrocortisone and insulin. None of the
lines formed colonies in agar (5 x 10W cells in DMEM/10%o
fetal calf serum), and of the six tested for growth in nude mice
(see Table 3) none formed tumors (107 cells injected subcu-
taneously).
When grown on plastic many of the cell lines formed dome-
like structures, and in one case (MTSV-1.5) structures with
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FiG. 3. Southern blots ofrestriction enzyme digests ofDNA from
immortalized lines. Samples (15 ,ug) of genomic DNA were digested
with EcoRI (a), BamHI (b), orXba 1 (c), fractionated on 1% agarose
gels, blotted onto Hybond-C membranes (Amersham) and probed
with a radioactive 850-base pair BamHI fragment from SV40 LT. kb,
Kilobases. Restriction sites in the recombinant retrovirus are shown
in the diagram. EcoRI cuts once within SV40 DNA, but not within
the region encoding T antigen (SV40 LT). LTR, long terminal repeat.
In a, overnight exposure offilm for MTSV lanes, 7-day exposure for
MRSV lanes.
lines formed lobular structures, while others formed branching
ducts. A more detailed description of the morphological struc-
tures developing in collagen gels will be given elsewhere.
Integration and Expression of SV40 T Antigen. To deter-
mine the number of integration sites, DNA from the three
transfected lines (MTSV series) and from several retrovirally
infected lines (MRSV series) was digested with EcoRI and
Southern blots were probed with a fragment of the SV40 T
antigen sequence. Fig. 3a reveals that, in contrast to the
multiple integration sites seen with the transfected lines, only
one is seen in the MRSV lines. Moreover, the transfected cell
lines appear to contain many more copies of the SV40 T
antigen genes, since the intensity of the bands in the sepa-
rated digests is much higher in the MTSV lines (see legend to
Fig. 3). In the case of MRSV series, the differences in the
intensity of the signal seen between lanes in Fig. 3 b and c
suggest that although several lines contain a single copy ofthe
SV40 T antigen gene, amplification of the integrated DNA
may have occurred in some lines, possibly by chromosomal
duplication. In spite of the differences in copy number, the
expression of SV40 T antigen detected by antibodies was
high in all the cell lines. As expected, the expression of p53,
which binds to SV40 T antigen, also increased, as detected by
staining with antibodies to the amino- or carboxyl-terminal
part of this molecule (data not shown).
Several cell lines were analyzed for chromosome content,
and these showed a modal number in the hyperdiploid range,
with a relatively broad peak; a diploid peak was also seen
with the MTSV-1.7 and MRSV-4.2 lines. A high coefficient
of variation, reflecting a wide spread of chromosome num-
bers in individual mitotic cells, is common in cells expressing
an integrated SV40 T antigen gene.
Effect of v-Ha-ras on Immortalized Lines. Since the immor-
talized lines are nontumorigenic, they should be useful re-
cipients for examining the effect of oncogenes on mammary
epithelial cells. Accordingly we examined the effect of the
introduction of the v-Ha-ras oncogene by infection with
pZiprashygro retrovirus on the growth properties of two of
the cell lines (MTSV-1.7 from group 1 and MRSV-3.1 from
group 2). Surprisingly, most of the hygromycin-resistant
clones from the pZiprashygro infection senesced quickly, but
in each case one clone could be further passaged up to
passage 7, at which time growth stopped, and in the case of
MRSV-3.1, did not start again. After 3 months, however, the
ras-containing clone from MTSV-1.7 resumed growth and
became an immortal cell line that formed colonies in agar with
an efficiency of 10% and induced tumors in the nude mouse
with an efficiency of 40%.
DISCUSSION
Available evidence suggests that the cells which are trans-
formed in vivo and which eventually become the invasive
cells in breast carcinomas reside in the TDLUs (27) and
belong to the luminal cell lineage (12). Since cells with this
phenotype have a short life-span in vitro, it has been difficult
to study the process of carcinogenesis in this cell type in
culture. Here we describe the use of SV40 T antigen to
immortalize luminal epithelial cells cultured from human milk
and the characterization of 17 nontumorigenic cell lines,
many of which have retained features of the common luminal
epithelial cell. To our knowledge this represents the first
series of cell lines definitively identified as being in the
luminal cell lineage. The phenotype of cell lines in group 1 is
of particular importance because this pattern of keratin
expression (keratins 7, 8, 18, and 19, but not 14) is seen both
in the common normal luminal epithelial cell in the TDLU
and in most invasive breast cancer cells (4).
Cell lines have previously been developed from breast
epithelial cells cultured from milk (6) or from reduction
Cell Biology: Bartek et al.
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Cell In basal lager(14+)
t t with high proliferative
mgoepithelium potential
+19 Transit cell in luminal
lager expressing keratins
8 and 18 but not 19
myoepithelium (Group 3 lines?)
.19 Differentiated luminal cell
expressing keratins 8, 18 and 19
myoepithelium (Group 1 lines?)
FIG. 4. Possible keratin phenotypes in the luminal cell lineage in
the human mammary gland.
mammoplasty tissue (7), but the efficiency with which on-
cogenes were introduced (viral infection, transfection) was
low, and the cell lines did not show features of the differen-
tiated luminal cell. Infection with an SV40 T-antigen-
encoding retrovirus proved to be an extremely efficient
method for immortalizing the luminal epithelial cells, and it
was also possible to introduce a single copy of the gene, in
contrast to the complex integration pattern seen in trans-
fected cells. With both methods, however, immortalization
was achieved in most cases (12/17) without the cells passing
through the "crisis" period typically seen with SV40-
transformed fibroblasts. In contrast, all of the clones ob-
tained that resembled the elongated cells found in small
numbers in milk (C phenotype) entered crisis early and did
not emerge to become immortal cell lines. This observation
was unexpected because the elongated cells go through more
divisions in culture.
On the basis of studies of the expression of keratins and
differentiation antigens in the adult mammary gland (1), in the
developing gland (28), and in cell cultures (2) we have
suggested that the luminal epithelial cell differentiates from a
cell in the basal layer (which expresses keratin 14), and that
the keratin 19-negative luminal cell derives from this cell and
is precursor to the 19-positive more-differentiated luminal
cell (see Fig. 4). The fact that cell lines can be developed that
express keratin 19 homogeneously and do not express keratin
14 suggests that these cells have passed a stage in the lineage
when keratin 14 is not induced in culture. On the other hand,
if the 19-negative luminal cells do indeed represent a transit
cell population originating from 14-positive cells in the basal
layer, it is possible that these cells could be induced to
express keratin 14 in culture and would correspond to the
group 3 cell lines. In the lineage scheme suggested in Fig. 4,
the group 2 lines could represent a subgroup of luminal cells
that have begun to express keratin 19 but in which keratin 14
expression may still be induced in culture. As yet we have not
been able to relate the phenotype of the cells in group 4 (B
phenotype) to the epithelial cells seen in vivo. They do,
however, resemble the "open" type colony which can be
seen in primary milk cultures (6).
Since the lines we have developed do not grow in agar or
in the nude mouse, and they exhibit many features of the
luminal epithelial cell from the human mammary gland, they
represent appropriate recipients for testing the effect of other
oncogenes on this cell type. When an activated v-Ha-ras
oncogene was introduced into two cell lines it was found that
most of the antibiotic-resistant clones senesced, although
after a crisis period one cell line emerged that grows well in
agar and in the nude mouse. An inhibitory effect of ras has
been observed in REF52 cells (29) and in rat Schwann cells
(30), but in these instances, SV40 T antigen expression
rescued the cells from ras-induced growth arrest. It may be
relevant that activated ras oncogenes have not been detected
in primary breast cancers and only occasionally in metastatic
lesions (31). Our results emphasize the importance of cell
phenotype in defining the cellular response to a specific
oncogene and support the idea that the immortalized lines
described here will be valuable tools in studying carcinogen-
esis in the human mammary gland.
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